Stocksigma LogoStocksigma Logo

Godavari Biorefineries Reports Strong Q2 FY27 Operating Turnaround Driven by Bio-Chemicals

Godavari Biorefineries reported a 26.6% YoY rise in Q2 FY27 total income to ₹549.8 Cr, with EBITDA turning positive to ₹10.9 Cr (2.0% margin) from negative

Godavari Biorefineries Reports Strong Q2 FY27 Operating Turnaround Driven by Bio-Chemicals

Godavari Biorefineries Ltd · Investor Presentation · 06 Nov 2026, 3:31 am

Godavari Biorefineries Reports Strong Q2 FY27 Operating Turnaround Driven by Bio-Chemicals Godavari Biorefineries reported a 26.6% YoY rise in Q2 FY27 total income to ₹549.8 Cr, with EBITDA turning positive to ₹10.9 Cr (2.0% margin) from negative ₹4.4 Cr in Q2 FY26. Net loss narrowed 63.4% YoY to ₹15.2 Cr. Growth was led by the Bio-based Chemicals segment, where revenue rose 39% YoY to ₹204.2 Cr and EBITDA grew 47% YoY to ₹22.1 Cr. Conversely, Integrated Sugar and Ethanol faced margin shrinkage due to higher feedstock costs and reduced corn-ethanol tender prices.

Original exchange filing (PDF)

More announcements from Godavari Biorefineries Ltd

All Godavari Biorefineries Ltd announcements